SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055719
Filing Date
2024-05-08
Accepted
2024-05-08 16:20:38
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-20240331.htm   iXBRL 10-Q 1358624
2 EX-31.1 crsp-ex31_1.htm EX-31.1 11373
3 EX-31.2 crsp-ex31_2.htm EX-31.2 11373
4 EX-32.1 crsp-ex32_1.htm EX-32.1 10061
  Complete submission text file 0000950170-24-055719.txt   6168612

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crsp-20240331.xsd EX-101.SCH 882378
61 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20240331_htm.xml XML 1135150
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 24926499
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)